Humoral immune response after vaccination against influenza in patients with breast cancer

By Brydak L.B.   Guzy J.   Starzyk J.   Machała M.   Góźdź S.S.  

Supportive Care in Cancer, Vol. 9, Iss. 1, 2001-01 ,pp. : 65-68

Springer Publishing Company

Access to resources Recommend Favorite

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite

Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal follow-up

By Dai Ming-Shen  

Supportive Care in Cancer, Vol. 12, Iss. 3, 2004-03 ,pp. : 191-196

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer

By Tulbah Asma   Ibrahim Ezzeldin   Ezzat Adnan   Ajarim Dahish   Rahal Mohammed   Weshi Amr   Sorbris Ralph  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 15-23

Humana Press, Inc

Access to resources Recommend Favorite

Circulating miR-200c Levels Significantly Predict Response to Chemotherapy and Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer

By Tanaka Koji   Miyata Hiroshi   Yamasaki Makoto   Sugimura Keijiro   Takahashi Tsuyoshi   Kurokawa Yukinori   Nakajima Kiyokazu   Takiguchi Shuji   Mori Masaki   Doki Yuichiro  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 607-615

Springer Publishing Company

Access to resources Recommend Favorite